Research

CanLyme is dedicated to promoting advancements in Lyme disease research. More research is needed to accurately diagnose and treat Lyme disease and other tick-borne illnesses, and CanLyme supports this.  CanLyme’s Venture Grants policy for academic researchers can be found here.

dummy-img

Whole-Genome Sequences of Thirteen Isolates of Borrelia burgdorferi

Jul 21, 2012

Borrelia burgdorferi is a causative agent of Lyme disease in…

dummy-img

CSM Murray Award Lecture – Functional studies of the Lyme disease spirochete – from molecules to mice

Jul 21, 2012

Department of Biochemistry & Molecular Biology, and Department of Microbiology…

dummy-img

Regional Cerebral Blood Flow and Metabolic Rate in Persistent Lyme Encephalopathy

Jul 21, 2012

There is controversy regarding whether objective neurobiological abnormalities exist after…

dummy-img

A Twist On Lyme: The Challenge of Diagnosing European Lyme Neuroborreliosis

Jul 21, 2012

Lyme neuroborreliosis is a tick-borne illness with central and peripheral…

dummy-img

Metagenomic Profile of the Bacterial Communities Associated with Ixodes ricinus Ticks.

Oct 27, 2011

Assessment of the microbial diversity residing in arthropod vectors of…

dummy-img

Human to human transmission of tick-borne disease

Oct 25, 2011

Human granulocytic anaplasmosis (HGA) is an emerging tick-borne disease in…

dummy-img

5-year follow-up study of patients with neuroborreliosis.

Oct 25, 2011

The objective of the follow-up study was to determine the…

dummy-img

Study supports chronic Lyme

Oct 25, 2011

The Lyme disease spirochete, Borrelia burgdorferi, is an extracellular microbe…

dummy-img

How the Neutrophil Both Kills and Protects the Lyme Spirochete, Borrelia Burgdorferi

Oct 25, 2011

My research focuses on the functions of phagocytic cells, both…

dummy-img

Experts identify molecular players in tick-borne illness

Oct 25, 2011

University scientists have made a key advance in understanding the…

dummy-img

The Klempner Article

Oct 25, 2011

The recent article in the NEJM, “Two Controlled Trials of…